| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO & CBO | Mar 11, 2024 | Sale | $0.67 | 18,931 | 12,680 | 227,210 | Mar 12, 2024, 09:45 PM | |
| CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO & CBO | Mar 13, 2023 | Sale | $1.53 | 6,648 | 10,171 | 148,141 | Mar 13, 2023, 09:20 PM | |
| CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO & CBO | Sep 19, 2022 | Sale | $0.77 | 15,642 | 12,035 | 150,789 | Sep 19, 2022, 08:28 PM | |
| CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO & CBO | Mar 31, 2022 | Option Exercise | $0.83 | 24,820 | 20,601 | 112,431 | Apr 04, 2022, 05:21 PM | |
| CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO & CBO | Nov 12, 2021 | Buy | $1.54 | 20,000 | 30,800 | 20,000 | Nov 15, 2021, 06:38 PM | |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Shah Preetam | EVP, CFO and Treasurer | Dec 30, 2020 | Option Exercise | $4.64 | 25,000 | 116,000 | 11,600 | Dec 31, 2020, 09:20 PM | |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Shah Preetam | EVP, CFO and Treasurer | Dec 24, 2019 | Buy | $3.96 | 11,600 | 45,929 | 36,600 | Dec 27, 2019, 07:01 AM |
Menu